X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13844) 13844
Book Review (2079) 2079
Publication (1043) 1043
Book Chapter (43) 43
Dissertation (25) 25
Conference Proceeding (18) 18
Data Set (1) 1
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
poor-prognosis (12414) 12414
index medicus (10142) 10142
humans (9114) 9114
oncology (6716) 6716
female (5658) 5658
prognosis (4946) 4946
male (4275) 4275
cancer (4253) 4253
middle aged (4140) 4140
expression (3810) 3810
aged (3345) 3345
metastasis (3341) 3341
adult (3150) 3150
gene expression (2055) 2055
immunohistochemistry (2023) 2023
survival (1955) 1955
tumors (1931) 1931
cell line, tumor (1845) 1845
cell biology (1813) 1813
carcinoma (1762) 1762
analysis (1732) 1732
gene expression regulation, neoplastic (1726) 1726
breast-cancer (1688) 1688
medical prognosis (1688) 1688
apoptosis (1656) 1656
pathology (1624) 1624
animals (1616) 1616
aged, 80 and over (1607) 1607
genetic aspects (1538) 1538
research (1512) 1512
proteins (1479) 1479
development and progression (1466) 1466
proliferation (1338) 1338
chemotherapy (1295) 1295
neoplasm staging (1241) 1241
overexpression (1206) 1206
breast cancer (1202) 1202
health aspects (1199) 1199
invasion (1196) 1196
cell proliferation (1193) 1193
progression (1193) 1193
care and treatment (1191) 1191
hematology (1089) 1089
colorectal-cancer (1085) 1085
down-regulation (1083) 1083
biomarkers (1061) 1061
up-regulation (1004) 1004
mice (994) 994
biochemistry & molecular biology (993) 993
colorectal cancer (993) 993
survival analysis (985) 985
medicine, research & experimental (966) 966
surgery (947) 947
disease-free survival (926) 926
epithelial-mesenchymal transition (912) 912
hepatocellular-carcinoma (912) 912
lung-cancer (902) 902
biomarkers, tumor - metabolism (890) 890
studies (864) 864
retrospective studies (861) 861
biomarkers, tumor - genetics (857) 857
squamous-cell carcinoma (845) 845
lung cancer (837) 837
gastric-cancer (834) 834
kaplan-meier estimate (831) 831
growth (830) 830
cell cycle (823) 823
survival rate (802) 802
gene (795) 795
mutation (791) 791
cell growth (785) 785
signal transduction (776) 776
treatment outcome (765) 765
adenocarcinoma (759) 759
cells (754) 754
gene-expression (752) 752
diagnosis (751) 751
risk factors (747) 747
poor prognosis (741) 741
migration (730) 730
genes (711) 711
kinases (705) 705
multivariate analysis (704) 704
patients (697) 697
adolescent (689) 689
metastases (679) 679
neoplasm invasiveness (678) 678
disease progression (672) 672
angiogenesis (661) 661
abridged index medicus (659) 659
cancer therapies (654) 654
squamous cell carcinoma (642) 642
medicine & public health (626) 626
proportional hazards models (618) 618
medicine (617) 617
article (613) 613
rna, long noncoding - genetics (610) 610
research article (607) 607
tumorigenesis (593) 593
hepatocellular carcinoma (591) 591
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13701) 13701
French (45) 45
German (41) 41
Spanish (23) 23
Russian (15) 15
Japanese (14) 14
Polish (10) 10
Korean (9) 9
Chinese (4) 4
Turkish (3) 3
Hungarian (1) 1
Italian (1) 1
Portuguese (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF ONCOLOGY, ISSN 1687-8450, 07/2019, Volume 2019, pp. 1 - 11
Background. The inflammation and nutrition play an important role in prognosis. A novel index combined with inflammatory and nutritional biomarkers, named... 
SURGERY | ONCOLOGY | POOR-PROGNOSIS
Journal Article
ACTA HAEMATOLOGICA, ISSN 0001-5792, 2017, Volume 137, Issue 2, pp. 73 - 75
Journal Article
Haematologica, ISSN 0390-6078, 09/2018, Volume 103, Issue 10, pp. 1581 - 1583
Journal Article
NATURE REVIEWS DRUG DISCOVERY, ISSN 1474-1776, 03/2017, Volume 16, Issue 3, pp. 203 - 221
In just over two decades since the discovery of the first microRNA (miRNA), the field of miRNA biology has expanded considerably. Insights into the roles of... 
EPITHELIAL-MESENCHYMAL TRANSITION | BREAST-CANCER | LUNG-CANCER | GROWTH-FACTOR-BETA | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | POOR-PROGNOSIS | IN-VIVO | DOWN-REGULATION | TUMOR-SUPPRESSOR | PHARMACOLOGY & PHARMACY | OVARIAN-CANCER | MIR-200 FAMILY
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 2019, Volume 25, Issue 10, pp. 3128 - 3140
Purpose: We identified for the first time that C8orf76 (chromosome 8 open reading frame 76) is preferentially amplified in gastric cancer. We elucidated its... 
SURVIVAL | AMPLIFICATION | ONCOLOGY | POOR-PROGNOSIS | MYC | TUMOR-SUPPRESSOR | PROLIFERATION | HER2
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 04/2019, Volume 25, Issue 14, pp. 4431 - 4442
Four consensus molecular subtypes (CMS1-4) of colorectal cancer were identified in primary tumors and found to be associated with distinctive biological... 
TARGET | ONCOLOGY | STATISTICS | COLORECTAL-CANCER | POOR-PROGNOSIS | BRAF | STAGE-II
Journal Article
Pathology - Research and Practice, ISSN 0344-0338, 06/2019, Volume 215, Issue 6, pp. 152374 - 152374
EZH2 is a core component of the polycomb repressive complex 2 (PRC2), which catalyzes trimethylation of histone H3 lysine 27 (H3K27me3) and promotes... 
Proliferation | Gastric cancer | Poor prognosis | p21 | EZH2
Journal Article
12/2010
Introduction: The optimal radiotherapeutic management of poor-prognosis (elderly and/or poor performance status) high-grade gliomas (HGG) remains... 
Compliance | high-grade glioma | poor-prognosis | hypofractionated radiotherapy
Web Resource
ANTICANCER RESEARCH, ISSN 0250-7005, 03/2015, Volume 35, Issue 3, pp. 1385 - 1388
Background/Aim: A long noncoding RNA (IncRNA) activated by transforming growth factor (TGF)-beta (IncRNA-ATB) was recently described to promote the... 
TGF-beta | colorectal cancer | METASTASIS | ONCOLOGY | POOR-PROGNOSIS | progression | CELL-CYCLE | Long noncoding RNA | prognosis | PROMOTES | EMT
Journal Article
Haematologica, ISSN 0390-6078, 09/2018, Volume 103, Issue 10, pp. 1662 - 1668
Therapy-related acute lymphoblastic leukemia remains poorly defined due to a lack of large data sets recognizing the defining characteristics of this entity.... 
MALIGNANCY | POOR-PROGNOSIS | SECONDARY | ADULTS | RISK | ACUTE MYELOID-LEUKEMIA | HEMATOLOGY
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 07/2015, Volume 5
Urinary bladder cancer (UBC) patients at muscle invasive stage have poor clinical outcome, due to high propensity for metastasis. Cancer-associated fibroblasts... 
NONCODING RNA SPRY4-IT1 | MICROENVIRONMENT | URINARY-BLADDER | POOR-PROGNOSIS | MULTIDISCIPLINARY SCIENCES | GROWTH | STROMAL FIBROBLASTS | OVARIAN-CANCER | EXPRESSION | CARCINOMA | PROGRESSION
Journal Article
JOURNAL OF NEUROSURGERY-SPINE, ISSN 1547-5654, 05/2017, Volume 26, Issue 5, pp. 652 - 652
Journal Article
Cancer Biology & Therapy, ISSN 1538-4047, 05/2019, Volume 20, Issue 5, pp. 593 - 596
A 65-year-old Caucasian female presented with abdominal symptoms and obstructive jaundice. She reported a significant pancreatic cancer history in her family.... 
poor prognosis | hospice | metastasis | chemotherapy | pancreas | squamous cell carcinoma | ONCOLOGY
Journal Article
Diagnostic Microbiology and Infectious Disease, ISSN 0732-8893, 05/2019
To evaluate clinical features and prognostic factors of non-albicans candidemia, we conducted a retrospective multicenter cohort study at 7 university... 
Journal Article
Cancer Epidemiology Biomarkers and Prevention, ISSN 1055-9965, 12/2014, Volume 23, Issue 12, pp. 2965 - 2970
Cancer cells expressing PD-1 ligands (PD-L1/PD-L2) inhibit immune-modulatory T-cell activation facilitating disease progression. Preliminary clinical trials... 
SURVIVAL | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | B7-H1 PD-L1 | MELANOMA | ONCOLOGY | SAFETY | POOR-PROGNOSIS | ANTI-PD-1 | HUMAN BREAST-CANCER | EXPRESSION | CARCINOMA | LYMPHOCYTES | Prognosis | Neoplasms - genetics | Humans | Female | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Disease Progression | Index Medicus
Journal Article
Nature Communications, ISSN 2041-1723, 06/2016, Volume 7, Issue 1, pp. 11996 - 11996
SARI, also called as BATF2, belongs to the BATF family and has been implicated in cancer cell growth inhibition. However, the role and mechanism of SARI in... 
BATF2 | ACTIVATION | METASTASIS | PROTEIN | BEVACIZUMAB | POOR-PROGNOSIS | MULTIDISCIPLINARY SCIENCES | RECEPTOR | AP-1 | DECREASED EXPRESSION | PROGRESSION | Index Medicus
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 11/2005, Volume 23, Issue 31, pp. 8033 - 8040
Purpose Vascular endothelial growth factor (VEGF) plays a key role in the biology and prognosis of pancreatic cancer. Inhibitors of VEGF suppress the growth of... 
SURVIVAL | NUDE-MICE | ANGIOGENESIS | ONCOLOGY | POOR-PROGNOSIS | ADENOCARCINOMA | RANDOMIZED-TRIAL | HIGH EXPRESSION | FACTOR RECEPTOR | METASTATIC COLORECTAL-CANCER | ENDOTHELIAL GROWTH-FACTOR
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.